LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by LENZ Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for LENZ Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| RA Capital Healthcare Fund LP | Director, 10% Owner | 694,755Indirect | Jun 15, 2026 | 1 |
| Ra Capital Management, L.P. | Director, 10% Owner | 694,755Indirect | Jun 15, 2026 | 1 |
| Kolchinsky Peter | Director, 10% Owner | 694,755Indirect | Jun 15, 2026 | 1 |
| Shah Rajeev M. | Director, 10% Owner | 694,755Indirect | Jun 15, 2026 | 1 |
| RA Capital Nexus Fund II, L.P. | Director | 694,755Indirect | Jun 15, 2026 | 1 |
| McCollum James W | Director | 10,500 | Jun 15, 2026 | 2 |
| Thunen Shelley B | Director | – | Jun 15, 2026 | 1 |
| Drapkin Kimberlee C | Director | – | Jun 15, 2026 | 1 |
| George Jeffrey P. | Director | 5,592 | Jun 15, 2026 | 2 |
| Scheiner Zachary | Director | – | Jun 15, 2026 | 1 |
| Guerard Frederic | Director | – | Jun 15, 2026 | 1 |
| Chevallard Daniel R. | Chief Financial Officer | 12,886 | Mar 30, 2026 | 3 |
| Schimmelpennink Evert B. | President, CEO and Secretary | 77,289 | Mar 30, 2026 | 2 |
| Olsson Shawn | Chief Commercial Officer | 4,733 | Jan 6, 2026 | 2 |
| Odrich Marc | Chief Medical Officer | 99,599 | Jan 6, 2026 | 1 |
| Versant Venture Capital VI, L.P. | 10% Owner | 764,127Indirect | Oct 2, 2025 | 1 |
| Versant Venture Capital VII, L.P. | 10% Owner | 764,127Indirect | Oct 2, 2025 | 1 |
| Versant Ventures VI GP-GP, LLC | 10% Owner | 764,127Indirect | Oct 2, 2025 | 1 |
| Versant Ventures VI GP, L.P. | 10% Owner | 764,127Indirect | Oct 2, 2025 | 1 |
| Versant Ventures VII GP, L.P. | 10% Owner | 764,127Indirect | Oct 2, 2025 | 1 |
| Versant Ventures VII GP-GP, LLC | 10% Owner | 764,127Indirect | Oct 2, 2025 | 1 |
| Versant Vantage II, L.P. | 10% Owner | 764,127Indirect | Oct 2, 2025 | 1 |
| Versant Vantage II GP-GP, LLC | 10% Owner | 764,127Indirect | Oct 2, 2025 | 1 |
| Versant Vantage II GP, L.P. | 10% Owner | 764,127Indirect | Oct 2, 2025 | 1 |
| Jimenez Joseph | Director | 161,941 | Jul 21, 2023 | 0 |
| Karsen Perry A | Director | 164,034 | Jul 21, 2023 | 0 |
| Hege Kristen | Director | – | Jul 21, 2023 | 0 |
| Jerel Davis | Director | 1,707,719Indirect | Jul 21, 2023 | 0 |
| Shah Smital | Director | 5,882Indirect | Jul 21, 2023 | 0 |
| Viney Joanne L. | Director | – | Jul 21, 2023 | 0 |
| Carlo Rizzuto | Director | – | Jul 21, 2023 | 0 |
| Bassan Abraham | Director | – | Jul 21, 2023 | 0 |
| Porteus Matthew | Director | – | Jul 21, 2023 | 0 |
| Lehrer-Graiwer Joshua | PRESIDENT AND CEO | 1,161,670 | Feb 23, 2023 | 0 |
| Young Alethia | Chief Financial Officer | – | Feb 23, 2023 | 0 |
| Akkaraju Srinivas | 10% Owner | 8,459,314Indirect | Apr 13, 2022 | 0 |
| Samsara BioCapital, L.P. | 10% Owner | 8,459,314Indirect | Apr 13, 2022 | 0 |
| Gutry Phil | CHIEF BUSINESS OFFICER | 299,941 | Apr 13, 2022 | 0 |
| 436, L.P. | 10% Owner | 37,753Indirect | Jul 1, 2021 | 0 |
| Stultz Katherine V | CHIEF OPERATING OFFICER | 216,020 | Jul 1, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 (view filing) | Mar 27 | 3 days | George Jeffrey P.Director | PPurchase | +5.59K | $8.92 | +$49.9K | New position5.59K after | |
| Mar 30, 2026 (view filing) | Mar 27 | 3 days | Schimmelpennink Evert B.President, CEO and Secretary | PPurchase | +28.1K | $8.95 | +$251.4K | +57.1%77.3K after | |
| Mar 30, 2026 (view filing) | Mar 27 | 3 days | Chevallard Daniel R.Chief Financial Officer | PPurchase | +7.50K | $8.57 | +$64.3K | +139.2%12.9K after | |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Olsson ShawnChief Commercial Officer | SSale | −10.0K | $26.10 | −$261.0K | −67.9%4.73K after | 2 lots10b5-1 |
| Nov 10, 2025 (view filing) | Nov 7 | 3 days | McCollum James WDirector | PPurchase | +10.5K | $22.79 | +$239.3K | New position10.5K after | |
| Nov 7, 2025 (view filing) | Nov 7 | Same day | Chevallard Daniel R.Chief Financial Officer | PPurchase | +2.20K | $22.76 | +$50.0K | +68.9%5.39K after | 2 lots |
| Oct 2, 2025 (view filing)4:40 PM ET | Sep 30 | 2 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −132.9K | $46.01 | −$6.12M | −11.2%1.05M after | 3 lots |
| Oct 2, 2025 (view filing)4:40 PM ET | Sep 30 | 2 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −92.0K | $46.01 | −$4.23M | −10.7%764.1K after | 3 lots |
| Sep 22, 2025 (view filing)4:23 PM ET | Sep 18 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −90.7K | $42.23 | −$3.83M | −7.1%1.18M after | 3 lots |
| Sep 22, 2025 (view filing)4:23 PM ET | Sep 18 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −44.6K | $42.23 | −$1.89M | −5.0%856.2K after | 3 lots |
| Aug 26, 2025 (view filing)7:59 PM ET | Aug 22-26 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −126.0K | $39.47 | −$4.97M | −9.0%1.27M after | 6 lots |
| Aug 26, 2025 (view filing)7:59 PM ET | Aug 22-26 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −62.1K | $39.47 | −$2.45M | −6.4%900.8K after | 6 lots |
| Aug 19, 2025 (view filing)4:51 PM ET | Aug 15-18 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −175.7K | $39.34 | −$6.91M | −11.1%1.40M after | 2 lots |
| Aug 19, 2025 (view filing)4:51 PM ET | Aug 15-18 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −85.0K | $39.33 | −$3.34M | −8.1%962.9K after | 2 lots |
| Jul 14, 2025 (view filing)4:50 PM ET | Jul 10 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −191.4K | $34.00 | −$6.51M | −10.8%1.58M after | |
| Jul 1, 2025 (view filing)6:16 PM ET | Jun 27 | 4 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −200.0K | $30.47 | −$6.09M | −10.2%1.77M after | |
| Jun 20, 2025 (view filing)5:50 PM ET | Jun 18-20 | 2 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −200.9K | $30.15 | −$6.06M | −16.1%1.05M after | 2 lots |
| Jun 20, 2025 (view filing)5:50 PM ET | Jun 20 | Same day | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −133.9K | $30.25 | −$4.05M | −6.4%1.97M after | |
| Jun 12, 2025 (view filing)4:37 PM ET | Jun 10 | 2 days | Versant Venture Capital VI, L.P. and 8 others10% Owner | SSale | −350.0K | $29.00 | −$10.2M | −21.9%1.25M after | |
| May 15, 2024 (view filing) | May 14 | 1 day | Chevallard Daniel R.Chief Financial Officer | PPurchase | +3.19K | $15.68 | +$50.0K | New position3.19K after | |
| May 14, 2024 (view filing) | May 13 | 1 day | McCollum James WDirector | PPurchase | +31.3K | $15.99 | +$501.0K | +6.3%525.6K after | |
| Mar 25, 2024 (view filing)8:48 PM ET | Mar 21 | 4 days | RA Capital Healthcare Fund LP and 4 othersDirector, 10% Owner | PPurchase | +933.0K | $15.03 | +$14.0M | +39.1%3.32M after | |
| Mar 25, 2024 (view filing)8:48 PM ET | Mar 21 | 4 days | RA Capital Healthcare Fund LP and 4 othersDirector, 10% Owner | PPurchaseCommon Stockj | +65.0K | $15.03 | +$976.5K | +10.3%694.8K after | |
| Apr 13, 2022 (view filing)7:40 PM ET | Apr 11-12 | 2 days | Akkaraju Srinivas and 1 other10% Owner | PPurchase | +424.5K | $4.08 | +$1.73M | +5.3%8.46M after | 2 lots |
| Apr 13, 2022 (view filing) | Apr 11 | 2 days | Gutry PhilCHIEF BUSINESS OFFICER | PPurchase | +5.00K | $4.01 | +$20.1K | +1.7%299.9K after | |
| Jan 25, 2022 (view filing)2:30 PM ET | Jan 21-24 | 4 days | Akkaraju Srinivas and 1 other10% Owner | PPurchase | +123.0K | $8.94 | +$1.10M | +1.6%8.03M after | 2 lots |
| Jan 21, 2022 (view filing)1:48 PM ET | Jan 19-20 | 2 days | Akkaraju Srinivas and 1 other10% Owner | PPurchase | +97.7K | $9.10 | +$888.7K | +1.2%7.91M after | 2 lots |
| Dec 20, 2021 (view filing)1:46 PM ET | Dec 15 | 5 daysLate | Akkaraju Srinivas and 1 other10% Owner | PPurchase | +22.3K | $10.19 | +$227.5K | +0.3%7.81M after | |
| Nov 24, 2021 (view filing)1:31 PM ET | Nov 22 | 2 days | Akkaraju Srinivas and 1 other10% Owner | PPurchase | +201.7K | $10.15 | +$2.05M | +2.7%7.79M after | |
| Oct 15, 2021 (view filing)6:06 PM ET | Oct 13-15 | 2 days | Akkaraju Srinivas and 1 other10% Owner | PPurchase | +50.8K | $13.14 | +$667.7K | +0.7%7.59M after | 3 lots |
| Oct 8, 2021 (view filing)5:09 PM ET | Oct 6-8 | 2 days | Akkaraju Srinivas and 1 other10% Owner | PPurchase | +145.5K | $13.53 | +$1.97M | +2.0%7.54M after | 3 lots |
| Jul 1, 2021 (view filing)7:01 PM ET | Jun 29 | 2 days | Versant Venture Capital VI, L.P. and 5 others10% Owner | PPurchase | +180.0K | $17.00 | +$3.06M | +11.8%1.71M after | Duplicate filing |
| Jul 1, 2021 (view filing)5:39 PM ET | Jun 29 | 2 days | Akkaraju Srinivas and 2 others10% Owner | PPurchase | +500.0K | $17.00 | +$8.50M | New position37.8K after | 2 lots |
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Jerel DavisDirector, 10% Owner | PPurchase | +180.0K | $17.00 | +$3.06M | +11.8%1.71M after | |
| Jul 1, 2021 (view filing) | Jun 29 | 2 days | Shah SmitalDirector | PPurchase | +5.88K | $17.00 | +$100.0K | New position5.88K after |